Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15CNS 6Gastrointestinal 5Gynecologic 4Tumor-Agnostic 2Thoracic 2Sarcoma 2Other solid neoplasm 2Head & Neck 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Locally Advanced Solid Tumor 1Advanced Solid Tumor 1

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × NVP-BKM120 × Other solid neoplasm × Clear all
NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Completed
47 enrolled
Other solid neoplasm

Locally Advanced Solid Tumor

NCT01283503 2020-12-08

A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors

Novartis

Phase 1 Completed
15 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡